Statistics for A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study
Total visits
| views | |
|---|---|
| A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study | 6 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Mamdani2021PhaseII-CCBY.pdf | 3 |
Top country views
| views | |
|---|---|
| United States | 5 |
| India | 1 |
Top city views
| views | |
|---|---|
| Bloomington | 2 |
| Indianapolis | 2 |
| Trenton | 1 |